Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to TradePhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to Trade

BridgeBio Pharma (BBIO) closed the last trading session at $35.68, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock NowPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now

Shares of Astellas Pharma Inc. (ALPMY) have been struggling lately and have lost 7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that

After Golden Cross, Telefonica Brasil (VIV)'s Technical Outlook is Bright
After Golden Cross, Telefonica Brasil (VIV)'s Technical Outlook is Bright

Telefonica Brasil S.A. (VIV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VIV's 50-day simple moving average crossed

ACCESS Newswire Inc. (ACCS) Q1 Earnings and Revenues Miss Estimates
ACCESS Newswire Inc. (ACCS) Q1 Earnings and Revenues Miss Estimates

ACCESS Newswire Inc. (ACCS) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ago

Here's Why Investors Should Consider Retaining Xylem Stock Now
Here's Why Investors Should Consider Retaining Xylem Stock Now

Xylem Inc. XYL is witnessing strength in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. Growth in

PTC Inc. (PTC) is a Top-Ranked Momentum Stock: Should You Buy?
PTC Inc. (PTC) is a Top-Ranked Momentum Stock: Should You Buy?

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why EQT Corporation (EQT) is a Top Momentum Stock for the Long-Term
Why EQT Corporation (EQT) is a Top Momentum Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why Adtalem Global Education (ATGE) is a Top Momentum Stock for the Long-Term
Why Adtalem Global Education (ATGE) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Why Comstock Resources (CRK) is a Top Momentum Stock for the Long-Term
Why Comstock Resources (CRK) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates
Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates

Stoke Therapeutics, Inc. (STOK) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of a loss of $0.37 per share. This compares to loss of $0.57 per share a

Century Aluminum's Q1 Earnings and Revenues Miss Estimates
Century Aluminum's Q1 Earnings and Revenues Miss Estimates

Century Aluminum Company CENX reported earnings of 28 cents per share for the first quarter of 2025, missing the Zacks Consensus Estimate of 53 cents. The figure compares favorably with the

Here's Why Carvana (CVNA) is a Strong Growth Stock
Here's Why Carvana (CVNA) is a Strong Growth Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Ross Stores (ROST) is a Strong Growth Stock
Here's Why Ross Stores (ROST) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Upbound Group (UPBD) is a Top Growth Stock for the Long-Term
Why Upbound Group (UPBD) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Fortinet (FTNT) is a Top Growth Stock for the Long-Term
Why Fortinet (FTNT) is a Top Growth Stock for the Long-Term

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Here's Why KBR Inc. (KBR) is a Strong Growth Stock
Here's Why KBR Inc. (KBR) is a Strong Growth Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research